Skip to content

ENGIMED

Active
Limited partnershipfounded 2017active for 8 yearsRue du Roi Chevalier 11, 1340 Ottignies-Louvain-la-Neuve, BelgiumKBO/BCE: BE 0683.853.067
Summary

ENGIMED has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €131,247 and a net result of €53,646. Equity is shrinking by about 19% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2027. Its solvency ranks better than 36% of 39,121 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

History

On 30 October 2017, ENGIMED was incorporated.1 Total assets went from €396,265 in 2021 to €342,140 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2021 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
30-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
28-05
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
25-07
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial Liquidity triplescurrent ratio 52.45
Current ratio from 17.36 to 52.45; short-term debt falls from €26,528 to €9,767.
31-12
Financial Equity above €500,000equity €504,254 ▲16.1%
A profit in every financial year since 2021 builds equity to €504,254.
20-06
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial Weakest financial yearnet €51,364 ▼46%
Net result drops to €51,364, the lowest in the series; recovery starts the following year.
30-11
NBB filing Annual accounts filed
financial year 2021 · micro format · 122 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts

We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.